# IM Olanzapine Versus Haloperidol or Midazolam

> **NCT02380118** · PHASE4 · TERMINATED · sponsor: **The University of Hong Kong** · enrollment: 167 (actual)

## Conditions studied

- Acute Agitation, Behavioural Emergency

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Haloperidol
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT02380118
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 167 (ACTUAL)
- **Why stopped:** Primary endpoint reached based on data projection from interim analysis.
- **Last updated:** 2022-11-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02380118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02380118, "IM Olanzapine Versus Haloperidol or Midazolam". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02380118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*